Article Details

Allergy, inflammation player Allakos reels in $100M series B

Retrieved on: 2017-12-13 06:07:30

Tags for this article:

Click the tags to see associated articles and topics

Allergy, inflammation player Allakos reels in $100M series B. View article details on hiswai:

Excerpt

<div>Five years after bagging a modest $30 million in series A financing, Allakos has picked up a hefty $100 million from the likes of <b>New Enterprise Associates</b>, Partner Fund Management and Roche Ventures. The funds will advance San Carlos, California-based Allakos' pipeline of antibodies developed for ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up